Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Boer

Showing results (151-160 of 314) with videos related to

Pageof 32
Sort By:
Journal of Clinical Microbiology|May 2, 2000
Computer-assisted analysis and epidemiological value of genotyping methods for Campylobacter jejuni and Campylobacter coliP de Boer, B Duim, A Rigter, et al.
Blood|January 1, 1993
Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in ratsB J de Smet, J P de Boer, J Agterberg, et al.
Clinical Rheumatology|July 31, 2007
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphomaF H Swaneveld, R M van Vugt, J P de Boer, et al.
Lancet (London, England)|September 12, 1998
Evidence of disturbed meiosis in a man referred for intracytoplasmic sperm injectionM H Pieters, R M Speed, P de Boer, et al.
Frontiers in Physiology|February 8, 2024
Recording ten-fold larger I<sub>Kr</sub> conductances with automated patch clamping using equimolar Cs<sup>+</sup> solutionsMeye Bloothooft, Bente Verbruggen, Fitzwilliam Seibertz, et al.
Immunopharmacology|September 1, 1992
Interplay of complement and cytokines in the pathogenesis of septic shockJ P de Boer, G J Wolbink, L G Thijs, et al.
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximabL Tran, J W Baars, J P de Boer, et al.
Agents and Actions. Supplements|January 1, 1992
Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patientsM Levi, C E Hack, J P de Boer, et al.
Nature Materials|July 19, 2005
The role of van der Waals forces in adhesion of micromachined surfacesFrank W Delrio, Maarten P de Boer, James A Knapp, et al.
The Journal of Clinical Investigation|October 1, 1991
Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivoM Levi, C E Hack, J P de Boer, et al.
Pageof 32

Showing results (151-160 of 314) with videos related to

Sort By:
Pageof 32
Journal of Clinical Microbiology|May 2, 2000
Computer-assisted analysis and epidemiological value of genotyping methods for Campylobacter jejuni and Campylobacter coliP de Boer, B Duim, A Rigter, et al.
Blood|January 1, 1993
Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in ratsB J de Smet, J P de Boer, J Agterberg, et al.
Clinical Rheumatology|July 31, 2007
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphomaF H Swaneveld, R M van Vugt, J P de Boer, et al.
Lancet (London, England)|September 12, 1998
Evidence of disturbed meiosis in a man referred for intracytoplasmic sperm injectionM H Pieters, R M Speed, P de Boer, et al.
Frontiers in Physiology|February 8, 2024
Recording ten-fold larger I<sub>Kr</sub> conductances with automated patch clamping using equimolar Cs<sup>+</sup> solutionsMeye Bloothooft, Bente Verbruggen, Fitzwilliam Seibertz, et al.
Immunopharmacology|September 1, 1992
Interplay of complement and cytokines in the pathogenesis of septic shockJ P de Boer, G J Wolbink, L G Thijs, et al.
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximabL Tran, J W Baars, J P de Boer, et al.
Agents and Actions. Supplements|January 1, 1992
Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patientsM Levi, C E Hack, J P de Boer, et al.
Nature Materials|July 19, 2005
The role of van der Waals forces in adhesion of micromachined surfacesFrank W Delrio, Maarten P de Boer, James A Knapp, et al.
The Journal of Clinical Investigation|October 1, 1991
Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivoM Levi, C E Hack, J P de Boer, et al.
Pageof 32